Deletion and Truncation Sequences

What Deletion and Truncation Sequences Are

A deletion sequence is missing one residue from somewhere in the middle of the intended chain, while every other residue is present in the correct order. A truncation sequence is missing one or more residues from one end of the chain, most often the amino terminus, because chain growth effectively stopped partway through synthesis and that shorter chain still carried through cleavage and workup as if it were finished.

Both are direct products of the same stepwise synthesis chemistry that builds the target peptide. They are not contamination introduced from an outside source, and they are not the result of degradation after the fact. They are formed at the same bench, in the same reaction vessel, by the same reagents, as the peptide the buyer intended to order. A related but distinct category is an insertion or substitution impurity, where the wrong residue was coupled at a given position rather than none at all, though this is generally rarer than deletion or truncation under normal synthesis conditions.

How Incomplete Coupling Produces Them

Solid-phase synthesis adds one amino acid per cycle to a growing, resin-bound chain. When a coupling reaction on a given cycle does not go to completion across every chain in the batch, some fraction of resin-bound chains are left without the intended residue attached at that position. If capping is used, that specific chain is permanently blocked from further growth and ends up as a truncated product. If capping is not used, or is itself incomplete, that chain can pick up the next residue anyway on a later cycle, producing a deletion sequence missing exactly the one residue it failed to add.

Because this happens on a chain-by-chain basis across millions of resin beads, and because coupling efficiency varies somewhat by residue and by position in the sequence, certain deletion variants show up more consistently than others for a given target sequence, particularly around residues known to be harder to couple, such as bulky or sterically hindered side chains. A synthesis chemist who has made a given sequence before often knows in advance which position is most likely to produce a deletion variant and can plan a double coupling or extended reaction time at that specific step to reduce it.

Why They Are Chemically Close to the Target

A deletion sequence differs from the target by exactly one amino acid out of what might be twenty, thirty, or more. A truncation sequence differs by one or a few residues from one end. In both cases, the overwhelming majority of the molecule, its overall size, its charge distribution, its hydrophobic and hydrophilic character, is identical or nearly identical to the target peptide.

Molecules that similar in structure behave similarly under almost any separation technique, because separation methods work by exploiting differences in physical and chemical properties between compounds. A deletion sequence missing a small, uncharged residue like alanine or glycine changes the molecule's overall hydrophobicity only slightly, which is exactly the property reverse-phase HPLC uses to separate compounds in the first place. A deletion of a larger, more hydrophobic residue such as leucine or phenylalanine tends to shift retention time more noticeably and is correspondingly easier to resolve from the target than the loss of a small residue would be.

Why That Closeness Makes Separation Hard

Purification exists to separate the target peak from everything around it, and separation quality depends on how differently two compounds behave on the column. A deletion or truncation sequence close in mass and hydrophobicity to the target elutes close in time to the target, sometimes close enough that the two peaks only partially resolve, or do not resolve at all under a given method.

Getting better separation usually means a longer gradient, a different column chemistry, or a second orthogonal purification pass using a different mechanism, such as ion-exchange chromatography after an initial reverse-phase pass. Each of those options adds cost, adds processing time, and typically reduces overall yield, since narrower cuts around the target peak throw away more borderline material to achieve a cleaner final result. That tradeoff between purity and yield is a real economic decision a manufacturer makes, and it is part of why purity and price move together across the peptide research supply market, and why a sequence known to be synthesis-difficult generally carries a higher price at a given purity tier than a straightforward one does.

How They Appear on a Chromatogram

On a chromatogram, deletion and truncation sequences typically appear as a small peak or a shoulder immediately adjacent to the main target peak, rather than as a well-separated, independent peak elsewhere on the trace. A shoulder that has not fully resolved from the main peak is the clearest visual signature of a closely related impurity, and it is exactly the kind of feature that automatic integration can misread, either splitting it out correctly or folding it into the main peak's area depending on where the baseline gets drawn.

A well-resolved chromatogram, with a clean, symmetric main peak and clearly separated minor peaks on either side, indicates a purification method that achieved good separation between the target and its close relatives. A crowded, poorly resolved region around the main peak is worth a direct question, since it may be masking impurity that a simple area percent number does not fully capture, particularly on an older or lower-resolution instrument run under a fast, minimally optimized method.

How They Appear on a Mass Spectrum

Mass spectrometry resolves what a chromatogram alone cannot, because it measures mass directly rather than inferring identity from elution time. A deletion sequence missing one residue shows up as a distinct mass, offset from the target's expected mass by the mass of the missing residue, typically somewhere between 57 and 186 atomic mass units depending on which amino acid was left out. A truncation sequence shows a similar offset corresponding to whichever residues are missing from the chain end.

A clean mass spectrum shows a single dominant peak at the expected mass with minimal signal at other masses. A mass spectrum with a secondary peak at a mass consistent with the loss of a specific residue is direct evidence of a deletion sequence, even when that same impurity only appeared as a subtle shoulder or was invisible entirely on the chromatogram. This is precisely why a competent certificate of analysis pairs HPLC with mass spectrometry, most often electrospray ionization run in positive mode for peptide work, rather than relying on either instrument alone.

Why a Single Purity Number Hides Them

A single area percent purity figure reports the fraction of total peak area attributed to the main peak, but it says nothing about how many distinct impurities make up the remainder, how close those impurities sit to the main peak, or whether any of them are partially co-eluting and therefore undercounted rather than fully excluded.

Two lots can carry the same reported purity, for example ninety-eight percent, while one has its remaining two percent spread across several well-separated, unrelated minor peaks and the other has that same two percent concentrated in a single closely co-eluting deletion sequence sitting almost underneath the main peak. Those are meaningfully different analytical pictures that an area percent number alone cannot distinguish, and only reviewing the full trace, or the mass spectrum, actually tells them apart.

What to Ask a Supplier

A supplier working from real analytical data can usually speak to more than the headline purity figure. Useful questions include whether the chromatogram shows any partially resolved shoulders near the main peak, whether mass spectrometry was run on the same lot and what it showed, and whether the reported purity reflects manual review of the integration or only the software's default automatic result.

• Ask to see the full chromatogram, not just the summary purity line
• Ask whether mass spectrometry confirmed identity on the same lot, not a representative or historical lot
• Ask how the integration baseline was set around any visible shoulders

For research use only material where analytical precision matters to the work being done, this level of detail is a reasonable and normal request, not an unusual one, and a lab that generates its own data, rather than reselling someone else's certificate of analysis, should be able to answer all three without delay.